The Journal of Thoracic and Cardiovascular Surgery
Volume 166, Issue 5, November 2023, Pages e428-e429
CommentaryCommentary: Draining the cyclic GMP-AMP synthase from immunity, advancing heart transplant surgery through a translational science approach
References (14)
- et al.
ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP
Immunity
(2022) - et al.
Mutant p53 suppresses innate immune signaling to promote tumorigenesis
Cancer Cell
(2021) - et al.
Cardiomyocytic cyclic GMP-AMP synthase is critical for the induction of experimental cardiac graft rejection
J Thorac Cardiovasc Surg
(2023) - et al.
Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway
Science
(2013) - et al.
Ubiquitin-like conjugation by bacterial cGAS enhances anti-phage defence
Nature
(2023) - et al.
YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS-STING
Nature
(2022) - et al.
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19
Nature
(2022)
There are more references available in the full text version of this article.
Cited by (0)
Disclosures: The authors reported no conflicts of interest.
The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.
© 2023 by The American Association for Thoracic Surgery